B7-H1 Expressed by Activated CD8 T Cells Is Essential for Their Survival

An immunoinhibitory role of B7 homologue 1 (B7-H1) expressed by non-T cells has been established; however, the function of B7-H1 expressed by T cells is not clear. Peak expression of B7-H1 on Ag-primed CD8 T cells was observed during the contraction phase of an immune response. Unexpectedly, B7-H1 blockade at this stage reduced the numbers of effector CD8 T cells, suggesting B7-H1 blocking Ab may disturb an unknown function of B7-H1 expressed by CD8 T cells. To exclusively examine the role of B7-H1 expressed by T cells, we introduced B7-H1 deficiency into TCR transgenic (OT-1) mice. Naive B7-H1–deficient CD8 T cells proliferated normally following Ag stimulation; however, once activated, they underwent more robust contraction in vivo and more apoptosis in vitro. In addition, B7-H1–deficient CD8 T cells were more sensitive to Ca-dependent and Fas ligand-dependent killing by cytotoxic T lymphocytes. Activation-induced Bcl-xL expression was lower in activated B7-H1–deficient CD8 T cells, whereas Bcl-2 and Bim expression were comparable to the wild type. Transfer of effector B7-H1–deficient CD8 T cells failed to suppress tumor growth in vivo. Thus, upregulation of B7-H1 on primed T cells helps effector T cells survive the contraction phase and consequently generate optimal protective immunity.

[1]  S. McSorley,et al.  B7-H1 (Programmed Cell Death Ligand 1) Is Required for the Development of Multifunctional Th1 Cells and Immunity to Primary, but Not Secondary, Salmonella Infection , 2010, The Journal of Immunology.

[2]  F. Aoudjit,et al.  Interleukin‐7 promotes the survival of human CD4+ effector/memory T cells by up‐regulating Bcl‐2 proteins and activating the JAK/STAT signalling pathway , 2010, Immunology.

[3]  J. Mulé,et al.  Blockade of Programmed Death Ligand 1 Enhances the Therapeutic Efficacy of Combination Immunotherapy against Melanoma , 2010, The Journal of Immunology.

[4]  Haidong Dong,et al.  TLR3-Stimulated Dendritic Cells Up-regulate B7-H1 Expression and Influence the Magnitude of CD8 T Cell Responses to Tumor Vaccination1 , 2009, The Journal of Immunology.

[5]  Lieping Chen,et al.  B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses. , 2008, Gastroenterology.

[6]  S. Way,et al.  PDL-1 Blockade Impedes T Cell Expansion and Protective Immunity Primed by Attenuated Listeria monocytogenes1 , 2008, The Journal of Immunology.

[7]  Lieping Chen,et al.  B7‐H1 restricts neuroantigen‐specific T cell responses and confines inflammatory CNS damage: Implications for the lesion pathogenesis of multiple sclerosis , 2008, European journal of immunology.

[8]  G. Freeman,et al.  PD-1 and its ligands in tolerance and immunity. , 2008, Annual review of immunology.

[9]  Lieping Chen,et al.  Blockade of endogenous B7‐H1 suppresses antibacterial protection after primary Listeria monocytogenes infection , 2008, Immunology.

[10]  J. Allison,et al.  The B7 Family and Cancer Therapy: Costimulation and Coinhibition , 2007, Clinical Cancer Research.

[11]  D. Getnet,et al.  Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells. , 2007, Blood.

[12]  Lieping Chen,et al.  The new B7s: playing a pivotal role in tumor immunity. , 2007, Journal of immunotherapy.

[13]  G. Pedraza-Alva,et al.  p38 Mitogen-Activated Protein Kinase Mediates the Fas-Induced Mitochondrial Death Pathway in CD8+ T Cells , 2006, Molecular and Cellular Biology.

[14]  I. Choi,et al.  Co-inhibitory role of T-cell-associated B7-H1 and B7-DC in the T-cell immune response. , 2006, Immunology letters.

[15]  S. Jayaraman.  Flow cytometric determination of mitochondrial membrane potential changes during apoptosis of T lymphocytic and pancreatic beta cell lines: comparison of tetramethylrhodamineethylester (TMRE), chloromethyl-X-rosamine (H2-CMX-Ros) and MitoTracker Red 580 (MTR580). , 2005, Journal of immunological methods.

[16]  G. Zhu,et al.  Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. , 2005, Cancer research.

[17]  Y. Stierhof,et al.  Fratricide of CD8+ cytotoxic T lymphocytes is dependent on cellular activation and perforin‐mediated killing , 2004, European journal of immunology.

[18]  G. Freeman,et al.  PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[19]  W. Tompkins,et al.  B7+CTLA4+ T cells engage in T-T cell interactions that mediate apoptosis: a model for lentivirus-induced T cell depletion. , 2004, Veterinary immunology and immunopathology.

[20]  C. Ahonen,et al.  Combined TLR and CD40 Triggering Induces Potent CD8+ T Cell Expansion with Variable Dependence on Type I IFN , 2004, The Journal of experimental medicine.

[21]  G. Zhu,et al.  B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes. , 2004, Immunity.

[22]  Lieping Chen,et al.  Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. , 2004, The Journal of clinical investigation.

[23]  Lieping Chen,et al.  Blockade of B7-H1 Suppresses the Development of Chronic Intestinal Inflammation 1 , 2003, The Journal of Immunology.

[24]  R. Koup,et al.  Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. , 2003, Journal of immunological methods.

[25]  Lieping Chen,et al.  B7-H1 pathway and its role in the evasion of tumor immunity , 2003, Journal of Molecular Medicine.

[26]  G. Zhu,et al.  Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis. , 2003, The Journal of clinical investigation.

[27]  D. Pardoll,et al.  Expression of Programmed Death 1 Ligands by Murine T Cells and APC1 , 2002, The Journal of Immunology.

[28]  J. Weber,et al.  Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I. , 2000, Immunity.

[29]  G. Zhu,et al.  B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion , 1999, Nature Medicine.

[30]  R. Lechler,et al.  T:T antigen presentation by activated murine CD8+ T cells induces anergy and apoptosis. , 1998, Journal of immunology.

[31]  M. Peter,et al.  Two CD95 (APO‐1/Fas) signaling pathways , 1998, The EMBO journal.

[32]  C. Thompson,et al.  CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. , 1995, Immunity.

[33]  R. Martin,et al.  CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. , 1994, Journal of immunological methods.

[34]  C. Blank,et al.  Negative regulation of T-cell function by PD-1. , 2004, Critical reviews in immunology.

[35]  G. Zhu,et al.  Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion , 2002, Nature Medicine.